Kyntra Bio Presents New Roxadustat Data on Improvements in Transfusion Independence Regardless of Ring Sideroblast Status in Patients with Anemia due to Lower-Risk Myelodysplastic Syndromes
Go back to Kyntra Bio Presents New Roxadustat Data on Improvements in Transfusion Independence Regardless of Ring Sideroblast Status in Patients with Anemia due to Lower-Risk Myelodysplastic Syndromes| (NASDAQ: KYNB) | Delayed: 6.88 +0.18 (2.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.70 | 52 Week High | $ | |||
| Open | $6.71 | 52 Week Low | $ | |||
| Day High | $6.91 | P/E | N/A | |||
| Day Low | $6.71 | EPS | $ | |||
| Volume | 4,558 | |||||
